{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:06:03Z","timestamp":1764079563499},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235139","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T18:24:59Z","timestamp":1592936699000},"page":"e0235139","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection"],"prefix":"10.1371","volume":"15","author":[{"given":"Andrea L.","family":"Herrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Van Hove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney K.","family":"Tweten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor C.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Diel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Chaussee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"issue":"7","key":"pone.0235139.ref001","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"DM Morens","year":"2008","journal-title":"The Journal of infectious diseases"},{"issue":"7","key":"pone.0235139.ref002","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1086\/511989","article-title":"The 1918 influenza pandemic: insights for the 21st century","volume":"195","author":"DM Morens","year":"2007","journal-title":"The Journal of infectious diseases"},{"key":"pone.0235139.ref003","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fmicb.2016.00342","article-title":"The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections","volume":"7","author":"AL Herrera","year":"2016","journal-title":"Frontiers in microbiology"},{"key":"pone.0235139.ref004","article-title":"Binding host proteins to the M protein contributes to the mortality associated with influenza-Streptococcus pyogenes superinfections","author":"AL Herrera","year":"2017","journal-title":"Microbiology (Reading, England)"},{"issue":"1","key":"pone.0235139.ref005","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1038\/s41598-018-29714-x","article-title":"The Streptococcus pyogenes fibronectin\/tenascin-binding protein PrtF.2 contributes to virulence in an influenza superinfection","volume":"8","author":"AL Herrera","year":"2018","journal-title":"Scientific reports"},{"issue":"3","key":"pone.0235139.ref006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1348-0421.12577","article-title":"Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus-group A Streptococcus superinfection","volume":"62","author":"S Okamoto","year":"2018","journal-title":"Microbiology and immunology"},{"issue":"10","key":"pone.0235139.ref007","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1128\/IAI.72.10.6068-6075.2004","article-title":"The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection","volume":"72","author":"S Okamoto","year":"2004","journal-title":"Infection and immunity"},{"issue":"7","key":"pone.0235139.ref008","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/JVI.77.7.4104-4112.2003","article-title":"Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice","volume":"77","author":"S Okamoto","year":"2003","journal-title":"Journal of virology"},{"issue":"17","key":"pone.0235139.ref009","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1128\/JVI.00369-12","article-title":"Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens","volume":"86","author":"JN Weeks-Gorospe","year":"2012","journal-title":"Journal of virology"},{"issue":"21\u201322","key":"pone.0235139.ref010","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2003.12.024","article-title":"Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection","volume":"22","author":"S Okamoto","year":"2004","journal-title":"Vaccine"},{"issue":"21","key":"pone.0235139.ref011","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2011.03.031","article-title":"Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections","volume":"29","author":"MS Chaussee","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"pone.0235139.ref012","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/irv.12658","article-title":"Associations between common respiratory viruses and invasive group A streptococcal infection: A time-series analysis","volume":"13","author":"B VB de Gier","year":"2019","journal-title":"Influenza and other respiratory viruses"},{"issue":"10","key":"pone.0235139.ref013","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1086\/652291","article-title":"Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza. Clinical infectious diseases: an official publication of the","volume":"50","author":"C Jean","year":"2010","journal-title":"Infectious Diseases Society of America"},{"issue":"5","key":"pone.0235139.ref014","article-title":"Group A streptococcal infections during the seasonal influenza outbreak 2010\/11 in South East England","volume":"16","author":"J Scaber","year":"2011","journal-title":"Euro surveillance: bulletin Europeen sur les maladies transmissibles"},{"issue":"6","key":"pone.0235139.ref015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.micpath.2010.06.012","article-title":"Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus","volume":"49","author":"RJ Olsen","year":"2010","journal-title":"Microbial pathogenesis"},{"issue":"4","key":"pone.0235139.ref016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archinte.163.4.467","article-title":"Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada","volume":"163","author":"MP Muller","year":"2003","journal-title":"Archives of internal medicine"},{"issue":"10","key":"pone.0235139.ref017","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","article-title":"Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection","volume":"187","author":"MR Batzloff","year":"2003","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"pone.0235139.ref018","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1128\/IAI.68.12.6587-6594.2000","article-title":"Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci","volume":"68","author":"ER Brandt","year":"2000","journal-title":"Infection and immunity"},{"issue":"3","key":"pone.0235139.ref019","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.148.3.888","article-title":"Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses","volume":"148","author":"MS Bronze","year":"1992","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"5","key":"pone.0235139.ref020","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.70.5.2734-2738.2002","article-title":"A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies","volume":"70","author":"C Olive","year":"2002","journal-title":"Infection and immunity"},{"issue":"5","key":"pone.0235139.ref021","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.72.5.2507-2512.2004","article-title":"Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections","volume":"72","author":"MA Hall","year":"2004","journal-title":"Infection and immunity"},{"issue":"6","key":"pone.0235139.ref022","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"KL Kotloff","year":"2004","journal-title":"Jama"},{"issue":"8","key":"pone.0235139.ref023","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers","volume":"41","author":"SA McNeil","year":"2005","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"40","key":"pone.0235139.ref024","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.vaccine.2014.06.093","article-title":"Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection","volume":"32","author":"JM Klonoski","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"pone.0235139.ref025","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1128\/IAI.68.11.6384-6390.2000","article-title":"Role of streptolysin O in a mouse model of invasive group A streptococcal disease","volume":"68","author":"B Limbago","year":"2000","journal-title":"Infection and immunity"},{"key":"pone.0235139.ref026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-micro-091014-104233","article-title":"The Unique Molecular Choreography of Giant Pore Formation by the Cholesterol-Dependent Cytolysins of Gram-Positive Bacteria","volume":"69","author":"RK Tweten","year":"2015","journal-title":"Annual review of microbiology"},{"issue":"3","key":"pone.0235139.ref027","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"JA McCullers","year":"2006","journal-title":"Clinical microbiology reviews"},{"issue":"12","key":"pone.0235139.ref028","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.4049\/jimmunol.170.12.6158","article-title":"Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice","volume":"170","author":"E Saeland","year":"2003","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"8","key":"pone.0235139.ref029","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.vaccine.2008.12.023","article-title":"A multi-valent vaccine approach that elicits broad immunity within an influenza subtype","volume":"27","author":"VC Huber","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"pone.0235139.ref030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"JB Dale","year":"1999","journal-title":"Vaccine"},{"issue":"27","key":"pone.0235139.ref031","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1021\/bi8005835","article-title":"Characterization of a streptococcal cholesterol-dependent cytolysin with a lewis y and b specific lectin domain","volume":"47","author":"S Farrand","year":"2008","journal-title":"Biochemistry"},{"key":"pone.0235139.ref032","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fimmu.2019.00363","article-title":"Senecavirus A 3C Protease Mediates Host Cell Apoptosis Late in Infection","volume":"10","author":"MHV Fernandes","year":"2019","journal-title":"Frontiers in immunology"},{"issue":"6","key":"pone.0235139.ref033","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/vim.2017.0193","article-title":"Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections","volume":"31","author":"JM Klonoski","year":"2018","journal-title":"Viral immunology"},{"key":"pone.0235139.ref034","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"1","key":"pone.0235139.ref035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/IAI.00927-12","article-title":"Identification and characterization of the first cholesterol-dependent cytolysins from Gram-negative bacteria","volume":"81","author":"EM Hotze","year":"2013","journal-title":"Infection and immunity"},{"issue":"1","key":"pone.0235139.ref036","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/IAI.47.1.52-60.1985","article-title":"Mechanism of membrane damage by streptolysin-O","volume":"47","author":"S Bhakdi","year":"1985","journal-title":"Infection and immunity"},{"issue":"2","key":"pone.0235139.ref037","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1074\/jbc.M804632200","article-title":"Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis","volume":"284","author":"AM Timmer","year":"2009","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"pone.0235139.ref038","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2958.2002.02876.x","article-title":"NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci","volume":"44","author":"AL Bricker","year":"2002","journal-title":"Molecular microbiology"},{"issue":"3","key":"pone.0235139.ref039","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1172\/JCI3065","article-title":"Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection","volume":"102","author":"CD Ashbaugh","year":"1998","journal-title":"The Journal of clinical investigation"},{"issue":"3","key":"pone.0235139.ref040","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2958.2005.04977.x","article-title":"Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein","volume":"59","author":"HS Courtney","year":"2006","journal-title":"Molecular microbiology"},{"key":"pone.0235139.ref041","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type-specific M antigens of group A streptococci","volume":"89","author":"RC Lancefield","year":"1962","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"1","key":"pone.0235139.ref042","doi-asserted-by":"crossref","first-page":"e00387","DOI":"10.1128\/mBio.00387-12","article-title":"Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence","volume":"4","author":"E Chiarot","year":"2013","journal-title":"mBio"},{"issue":"4","key":"pone.0235139.ref043","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/IAI.70.4.2166-2170.2002","article-title":"Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococci","volume":"70","author":"JB Dale","year":"2002","journal-title":"Infection and immunity"},{"issue":"2","key":"pone.0235139.ref044","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00693-19","article-title":"An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model","volume":"10","author":"T Rivera-Hernandez","year":"2019","journal-title":"mBio"},{"issue":"1","key":"pone.0235139.ref045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/infdis\/166.1.31","article-title":"Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988\u20131989","volume":"166","author":"SE Holm","year":"1992","journal-title":"The Journal of infectious diseases"},{"issue":"3","key":"pone.0235139.ref046","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/170.3.585","article-title":"Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease","volume":"170","author":"A Norrby-Teglund","year":"1994","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"pone.0235139.ref047","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/IAI.64.12.5395-5398.1996","article-title":"Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G","volume":"64","author":"A Norrby-Teglund","year":"1996","journal-title":"Infection and immunity"},{"issue":"6","key":"pone.0235139.ref048","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0012-3692(15)50887-8","article-title":"Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU","volume":"130","author":"S Mehta","year":"2006","journal-title":"Chest"},{"issue":"8","key":"pone.0235139.ref049","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.156.8.3057","article-title":"Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production","volume":"156","author":"A Norrby-Teglund","year":"1996","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"6","key":"pone.0235139.ref050","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/381979","article-title":"Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clinical infectious diseases: an official publication of the","volume":"38","author":"J Darenberg","year":"2004","journal-title":"Infectious Diseases Society of America"},{"issue":"9","key":"pone.0235139.ref051","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1592\/phco.19.13.1094.31589","article-title":"Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review","volume":"19","author":"MJ Cawley","year":"1999","journal-title":"Pharmacotherapy"},{"issue":"5","key":"pone.0235139.ref052","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1128\/IAI.66.5.2279-2283.1998","article-title":"Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections","volume":"66","author":"H Basma","year":"1998","journal-title":"Infection and immunity"},{"issue":"4","key":"pone.0235139.ref053","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2014a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"R Kaul","year":"1999","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"pone.0235139.ref054","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis","volume":"67","author":"T Parks","year":"2018","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"pone.0235139.ref055","first-page":"Cd001090","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","author":"MM Alejandria","year":"2013","journal-title":"The Cochrane database of systematic reviews"},{"issue":"7","key":"pone.0235139.ref056","first-page":"877","article-title":"Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals","volume":"64","author":"SS Kadri","year":"2017","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"pone.0235139.ref057","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/514588","article-title":"Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy","volume":"26","author":"A Norrby-Teglund","year":"1998","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"pone.0235139.ref058","doi-asserted-by":"crossref","first-page":"15825","DOI":"10.1038\/srep15825","article-title":"Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulin","volume":"5","author":"M Reglinski","year":"2015","journal-title":"Scientific reports"},{"issue":"5","key":"pone.0235139.ref059","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1172\/JCI116862","article-title":"Binding of cytokines to pharmaceutically prepared human immunoglobulin","volume":"92","author":"M Svenson","year":"1993","journal-title":"The Journal of clinical investigation"},{"issue":"5","key":"pone.0235139.ref060","article-title":"Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections","volume":"7","author":"SXW-LaJP Balthasar","year":"2018","journal-title":"Antibodies"},{"issue":"2","key":"pone.0235139.ref061","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/IAI.69.2.924-930.2001","article-title":"Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice","volume":"69","author":"S Kawabata","year":"2001","journal-title":"Infection and immunity"},{"issue":"11","key":"pone.0235139.ref062","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/infdis\/jir149","article-title":"Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor","volume":"203","author":"YS Huang","year":"2011","journal-title":"The Journal of infectious diseases"},{"key":"pone.0235139.ref063","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/978-1-4899-1825-3_214","article-title":"Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies","volume":"418","author":"JB Zabriskie","year":"1997","journal-title":"Advances in experimental medicine and biology"},{"issue":"4","key":"pone.0235139.ref064","doi-asserted-by":"crossref","first-page":"e5147","DOI":"10.1371\/journal.pone.0005147","article-title":"Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection","volume":"4","author":"M Pandey","year":"2009","journal-title":"PloS one"},{"issue":"2","key":"pone.0235139.ref065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.chom.2011.06.011","article-title":"The Hypervariable region of Streptococcus pyogenes M protein escapes antibody attack by antigenic variation and weak immunogenicity","volume":"10","author":"J Lannergard","year":"2011","journal-title":"Cell host & microbe"},{"issue":"31","key":"pone.0235139.ref066","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1016\/j.vaccine.2010.05.018","article-title":"Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes","volume":"28","author":"TA Penfound","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"pone.0235139.ref067","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1128\/IAI.00038-07","article-title":"Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci","volume":"75","author":"M Liu","year":"2007","journal-title":"Infection and immunity"},{"key":"pone.0235139.ref068","article-title":"Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vbeta-specific T cells","author":"JJ Zeppa","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"pone.0235139.ref069","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1084\/jem.167.6.1945","article-title":"Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A","volume":"167","author":"D Bessen","year":"1988","journal-title":"The Journal of experimental medicine"},{"issue":"12","key":"pone.0235139.ref070","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1128\/IAI.73.12.7878-7886.2005","article-title":"Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils","volume":"73","author":"HS Park","year":"2005","journal-title":"Infection and immunity"},{"issue":"26","key":"pone.0235139.ref071","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1016\/j.vaccine.2019.04.005","article-title":"Lessons for general vaccinology research from attempts to develop an HIV vaccine","volume":"37","author":"SZ Shapiro","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"pone.0235139.ref072","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14760584.2018.1484284","article-title":"Influenza vaccine failure: failure to protect or failure to understand?","volume":"17","author":"GA Poland","year":"2018","journal-title":"Expert review of vaccines"},{"issue":"Suppl 1","key":"pone.0235139.ref073","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/infdis\/165-Supplement_1-S121","article-title":"The biology of Haemophilus influenzae type b vaccination failure","volume":"165","author":"SJ Holmes","year":"1992","journal-title":"The Journal of infectious diseases"},{"issue":"50","key":"pone.0235139.ref074","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1016\/j.vaccine.2016.10.050","article-title":"Pneumococcal conjugate vaccine failure in children: A systematic review of the literature","volume":"34","author":"G Oligbu","year":"2016","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T21:06:58Z","timestamp":1696280818000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235139"}},"subtitle":[],"editor":[{"given":"Jens","family":"Kreth","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":74,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235139","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]}}}